Falls rise 27 percent across self-reporting U.S. healthcare facilities, review finds
By
Alicia Lasek
Apr 12, 2023
Serious safety events self-reported to The Joint Commission rose by 19% in 2022. The uptick is mostly attributable to falls, which increased by 27% overall, investigators say.
Weight loss linked to 10 percent higher mortality in elders, particularly men
By
Alicia Lasek
Apr 12, 2023
Study results highlight the importance of monitoring older patients who present with weight loss in the clinical setting, researchers say.
Clinical briefs for Wednesday, April 12
By
Alicia Lasek
Apr 12, 2023
Assisted living nurses can continue skilled nursing care under new law … HHS: Telehealth enforcement discretion to be discontinued with end of PHE … White House to invest $5B in next-generation COVID...
Tired CNAs, lack of specialist access affected residents’ well-being during pandemic: study
By
Alicia Lasek
Apr 10, 2023
A new study has pinpointed key factors that can serve as targets for improving residents’ quality of life, researchers say.
FDA advisors to weigh use of Rexulti for Alzheimer’s agitation
By
Alicia Lasek
Apr 10, 2023
Expert advisors are set to determine whether Rexulti (brexpiprazole) is effective and safe for this new application, the FDA announced Monday.
Universal screening to age 70 identifies diabetes in most cases
Apr 07, 2023
An age-based screening method (35 to 70) identifies the greatest proportion of adults with prediabetes and diabetes compared with USPSTF recommendations and BMI-based screening, investigators say.
Clinical briefs for Tuesday, April 11
By
Alicia Lasek
Apr 10, 2023
Massachusetts officials reject groups’ call to keep mask mandate after PHE expires … FDA experts to discuss full approval of Alzheimer’s drug Leqembi in June … USPSTF releases vitamin D and calcium...
66 percent of nursing home residents given antibiotics during stays, researchers report
By
Alicia Lasek
Apr 09, 2023
Results from a long-term study of Medicare Part D data shed light on antibiotic prescribing prevalence, the most common drug types and rate of therapy days for U.S. nursing home residents.
Benefits of Alzheimer’s drug Leqembi persist when treatment is halted, trial shows
By
Alicia Lasek
Apr 09, 2023
A relative slowing of cognitive decline continues for up to two years in patients who stop taking the recently authorized drug, clinical trial data reveal.
COVID-19 spreads by hand, surface contamination, first real-world study finds
By
Alicia Lasek
Apr 09, 2023
Researchers say they’ve found the first verifiable evidence that the presence of SARS-CoV-2 on hands and surfaces significantly contributes to the spread of COVID-19.